This #GUTRecentAdvancesInBasicScience review synthesises emerging evidence linking the microbiome to cardiovascular disease, highlighting shared inflammatory and metabolic pathways. Fusco et al. present Gut microbiota and atherosclerosis access it Full article: Gut microbes with the gbu genes determine TMAO production from L carnitine intake and serve as a biomarker for precision nutrition Trimethylamine N oxide, choline and its metabolites are associated with the risk of non alcoholic fatty liver disease British Journal of Nutrition Cambridge Core Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Gut Microbiome Derived Metabolite Trimethylamine N Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans Hypertension Dietary bioactive ingredients to modulate the gut microbiota derived metabolite TMAO. New opportunities for functional food development Food & Function (RSC Publishing) DOI:10.1039 D0FO01237H